Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06514222
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
None
First Post:
2024-07-08
Brief Title:
Pain Control Following Third Molar Surgery
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Pain Control Following Impacted Mandibular Third Molar Surgery A Comparison of the Effectiveness of Two Different Protocols
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In this study the investigators recruited patients undergoing surgical removal of impacted third molar teeth Participants will be randomly divided into two groups Group 1 The patient will receive 400mg of ibuprofen plus 1000mg of Paracetamol simultaneously every 8 hours for two days
Group 2- The patient will receive 400mg ibuprofen and 1000mg Paracetamol at 4 hours in intervals for two days With a total of 3 doses of ibuprofen and 3 doses of paracetamol per day Then pain control will be assessed using various primary and secondary outcome scales
Group 2- The patient will receive 400mg ibuprofen and 1000mg Paracetamol at 4 hours in intervals for two days With a total of 3 doses of ibuprofen and 3 doses of paracetamol per day Then pain control will be assessed using various primary and secondary outcome scales
Detailed Description:
Surgical removal of an impacted mandibular third molar is one of the most common procedures in oral and maxillofacial surgery Ten million third molars are extracted from approximately 5 million people in the United States each year Research suggests that wisdom tooth removal has an immediate negative impact on patients working and social lives in one study patients took an average of 16 days off work with over one-third of patients stating that the surgery had affected their performance at work Postoperative complications may include swelling bruising and limited mouth opening along with difficulty with eating which can be a major concern to patients and has not been appreciated by healthcare professionals in the past However patients are often most concerned about postoperative pain which may be severe Approximately one in two patients will experience pain despite analgesic therapy even one week after surgery The inflammatory response to surgical trauma is associated with edema discomfort dehiscence and trismus and these factors may affect the patients everyday life The control of these symptoms is frequently based on pharmacological manipulation of local and systemic pain and inflammation mediators Combining two analgesic agents with distinct mechanisms or sites of action such as combining a peripherally acting analgesic with a centrally acting analgesic has been advocated for many years A common example is the analgesic formulation containing acetaminophen combined with the opioid hydrocodone or paracetamol with ibuprofen The pain control of single showed that the maximum effect is recorded in the first 2 to 3 hours Combining two agents tends to increase the effect for 6 to 8 hours However as both medication actions commence simultaneously in the latter combination they are likely to fade in the same way This may make the patient likely to overdose on such medicine to ensure the continuity of pain relief This research aims to test the combination of classical pain medication but in a novel alternate way to minimize the dosage and avoid the risk of side effects and toxicity
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None